Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
aging
Biotech
ARPA-H designates up to $144M for anti-aging medical research
The biopharma beneficiaries of the anti-aging effort include Linnaeus Therapeutics, Cambrian BioPharma and Apollo Alpha.
Darren Incorvaia
Feb 25, 2026 11:55am
Chugai inks $250M deal for Gero’s age-related disease targets
Jul 7, 2025 3:00am
NewLimit raises $130M to push liver mRNA med into clinic
May 6, 2025 11:00am
BioAge secures Novartis deal worth up to $550M biobucks
Dec 18, 2024 10:44am
RANKL cytokine makes the thymus more youthful in mice
Dec 5, 2024 11:45am
Advantage spins out anti-aging R&D to new biotech Klothea
Nov 25, 2024 11:56am
